Purpose: To evaluate preoperative rectal electrical stimulation in the recovery of urinary continence in patients who undergo radical retropubic prostatectomy. Materials and Methods: Patients were divided into 3 randomized groups: control, pelvic exercises, and electrical stimulation. A 1 hour pad-test, the ICIQ-SF, and the SF-36 were performed 1, 3, and 6 months after the surgical procedure. Results: Of the 58 patients who were initially included in the study, 9 were excluded due to radiotherapy after surgical intervention, an indwelling urethral catheter for more than 30 days, high surgical risk, loss of follow-up, or incomplete participation in the study routines and spontaneous interruption. Forty-nine patients concluded the study (15 in the control group, 17 in the exercise group, and 17 in the electrical stimulation group). We did not observe any significant difference in the pad test (p > 0.05), the 8 domains of the SF-36, or ICIQ-SF score compared with control groups (control, exercise, and electrical stimulation). Conclusion: Preoperative rectal electrical stimulation has no impact on continence status in patients who undergo radical retropubic prostatectomy. There is no difference in the three above mentioned groups with regard to urinary leakage and quality of life.

Purpose: to prospectively assess symptoms and impairments following COVID-19 hospitalization in a cancer population, particularly regarding fatigue, nutritional status, speech and swallowing, anxiety, depression, and post-traumatic stress disorder (PTSD).Methods: Prospective and longitudinal cross-sectional study with cancer survivors hospitalized due to COVID-19 from June to December 2020. Participants were assessed at discharge, and after one, three, six and twelve months. Results: We included 51 participants. At the time of discharge, 84.3% participants presented at least one impairment: fatigue (68.6%), anxious/depressive symptoms (23.5%), voice and speech impairments (19.6%), dysphagia (21.6%), and were at nutritional risk (54.9%). After one year, impairments were present in 53.7% of the sample: fatigue (34.2%), anxious/depressive symptoms (39.2%), voice and speech impairments (29.4%), dysphagia (33.3%). No participants presented nutritional risk after one year. Participants had no significant impact on their activities of daily living (ADL).Conclusion: Cancer survivors hospitalized due to COVID-19 in our institution presented high levels of fatigue, nutritional risk, anxious/depressive and PTSD symptoms at the time of discharge, with improvement of fatigue, and some aggravation of speech, swallowing and psychological symptoms in the following year.